Ogden Christopher
Insider CIK 1914523 · CTMX SVP, Finance and Accounting
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| CTMX CytomX Therapeutics, Inc. | S Sale | 2026-06-15 | 2026-06-17 | 1,624 | $3.05 | $5.0K | 295,324 | SEC↗ |
| CTMX CytomX Therapeutics, Inc. | S Sale | 2026-03-17 | 2026-03-19 | 19,323 | $6.42 | $124.1K | 296,948 | SEC↗ |
| CTMX CytomX Therapeutics, Inc. | A Award deriv | 2026-02-02 | 2026-02-04 | 325,000 | — | $0 | 325,000 | SEC↗ |
| CTMX CytomX Therapeutics, Inc. | A Award | 2026-02-02 | 2026-02-04 | 90,000 | — | $0 | 316,271 | SEC↗ |
| CTMX CytomX Therapeutics, Inc. | A Award deriv | 2025-09-26 | 2025-09-30 | 78,250 | — | $0 | 78,250 | SEC↗ |
| CTMX CytomX Therapeutics, Inc. | A Award deriv | 2025-09-26 | 2025-09-30 | 39,150 | — | $0 | 39,150 | SEC↗ |
| CTMX CytomX Therapeutics, Inc. | S Sale | 2025-06-16 | 2025-06-17 | 10,614 | $2.69 | $28.6K | 226,271 | SEC↗ |
| CTMX CytomX Therapeutics, Inc. | M Exercise deriv | 2025-06-13 | 2025-06-17 | 37,500 | — | $0 | 0 | SEC↗ |
| CTMX CytomX Therapeutics, Inc. | S Sale | 2025-06-13 | 2025-06-17 | 1,641 | $2.95 | $4.8K | 199,385 | SEC↗ |
| CTMX CytomX Therapeutics, Inc. | M Exercise | 2025-06-13 | 2025-06-17 | 37,500 | — | $0 | 236,885 | SEC↗ |
| CTMX CytomX Therapeutics, Inc. | S Sale | 2025-03-18 | 2025-03-20 | 8,551 | $0.60 | $5.1K | 201,026 | SEC↗ |
| CTMX CytomX Therapeutics, Inc. | A Award deriv | 2025-02-04 | 2025-02-06 | 225,000 | — | $0 | 225,000 | SEC↗ |
| CTMX CytomX Therapeutics, Inc. | A Award deriv | 2025-02-04 | 2025-02-06 | 115,000 | — | $0 | 115,000 | SEC↗ |
| CTMX CytomX Therapeutics, Inc. | A Award | 2025-02-04 | 2025-02-06 | 57,500 | — | $0 | 209,577 | SEC↗ |
| CTMX CytomX Therapeutics, Inc. | A Award | 2025-02-04 | 2025-02-06 | 44,000 | — | $0 | 152,077 | SEC↗ |
| CTMX CytomX Therapeutics, Inc. | M Exercise deriv | 2024-08-20 | 2024-08-22 | 6,875 | — | $0 | 0 | SEC↗ |
| CTMX CytomX Therapeutics, Inc. | S Sale | 2024-08-20 | 2024-08-22 | 1,984 | $1.23 | $2.4K | 108,077 | SEC↗ |
| CTMX CytomX Therapeutics, Inc. | M Exercise | 2024-08-20 | 2024-08-22 | 6,875 | — | $0 | 110,061 | SEC↗ |
| CTMX CytomX Therapeutics, Inc. | A Award deriv | 2024-06-12 | 2024-06-14 | 75,000 | — | $0 | 75,000 | SEC↗ |
| CTMX CytomX Therapeutics, Inc. | A Award | 2024-06-12 | 2024-06-14 | 17,500 | — | $0 | 103,186 | SEC↗ |
| CTMX CytomX Therapeutics, Inc. | S Sale | 2024-03-19 | 2024-03-21 | 2,971 | $2.09 | $6.2K | 85,686 | SEC↗ |
| CTMX CytomX Therapeutics, Inc. | A Award deriv | 2024-01-18 | 2024-01-19 | 75,000 | — | $0 | 75,000 | SEC↗ |
| CTMX CytomX Therapeutics, Inc. | A Award deriv | 2024-01-18 | 2024-01-19 | 154,000 | — | $0 | 154,000 | SEC↗ |
| CTMX CytomX Therapeutics, Inc. | A Award | 2024-01-18 | 2024-01-19 | 40,000 | — | $0 | 88,657 | SEC↗ |
| CTMX CytomX Therapeutics, Inc. | S Sale | 2023-12-20 | 2023-12-22 | 1,990 | $1.38 | $2.7K | 48,657 | SEC↗ |
| CTMX CytomX Therapeutics, Inc. | M Exercise deriv | 2023-12-17 | 2023-12-19 | 6,875 | — | $0 | 6,875 | SEC↗ |
| CTMX CytomX Therapeutics, Inc. | M Exercise | 2023-12-17 | 2023-12-19 | 6,875 | — | $0 | 50,647 | SEC↗ |
| CTMX CytomX Therapeutics, Inc. | S Sale | 2023-03-16 | 2023-03-20 | 516 | $1.98 | $1.0K | 37,772 | SEC↗ |
| CTMX CytomX Therapeutics, Inc. | A Award deriv | 2023-02-02 | 2023-02-06 | 75,000 | — | $0 | 75,000 | SEC↗ |
| CTMX CytomX Therapeutics, Inc. | A Award deriv | 2023-02-02 | 2023-02-06 | 75,000 | — | $0 | 75,000 | SEC↗ |
| CTMX CytomX Therapeutics, Inc. | A Award | 2023-02-02 | 2023-02-06 | 25,000 | — | $0 | 38,288 | SEC↗ |
| CTMX CytomX Therapeutics, Inc. | A Award deriv | 2022-08-10 | 2022-08-12 | 82,500 | — | $0 | 82,500 | SEC↗ |
| CTMX CytomX Therapeutics, Inc. | A Award deriv | 2022-08-10 | 2022-08-12 | 13,750 | — | $0 | 13,750 | SEC↗ |